Chat with us
Research Assistance
Online
  • Please enter your first name.

Kuwait Eliquis Market Size & Outlook, 2025-2033

The eliquis market in Kuwait is expected to reach a projected revenue of US$ 37.0 million by 2033. A compound annual growth rate of -2.5% is expected of Kuwait eliquis market from 2025 to 2033.

  • Pharmaceuticals
    • Metabolic Disorders Treatment
      • Eliquis Market Outlook
Revenue, 2024 (US$M)
$42.0
Forecast, 2033 (US$M)
$37.0
CAGR, 2025 - 2033
-2.5%
Report Coverage
Kuwait
Prism AI by Grand View ResearchFree to try

Ask a question about the eliquis market

Every figure cited from GVR research

Kuwait eliquis market highlights

  • The Kuwait eliquis market generated a revenue of USD 42.0 million in 2024 and is expected to reach USD 37.0 million by 2033.
  • The Kuwait market is expected to grow at a CAGR of -2.5% from 2025 to 2033.
  • In terms of segment, atrial fibrillation (af) was the largest revenue generating indication in 2024.
  • Atrial Fibrillation (AF) is the most lucrative indication segment registering the fastest growth during the forecast period.


Eliquis market data book summary

Market revenue in 2024USD 42.0 million
Market revenue in 2033USD 37.0 million
Growth rate-2.5% (CAGR from 2025 to 2033)
Largest segmentAtrial fibrillation (af)
Fastest growing segmentAtrial Fibrillation (AF)
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAtrial Fibrillation (AF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Post-Operative VTE Prophylaxis (at-risk cases)


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.2% of the global eliquis market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, South Africa eliquis market is projected to lead the regional market in terms of revenue in 2033.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 59.3 million by 2033.

No credit card required*

Publish Date: Jul 22, 2025

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Eliquis Market Companies

NameProfile# EmployeesHQWebsite
Johnson & JohnsonView profile 134,400One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933www.jnj.com
Novartis AG ADRView profile 76,057Lichtstrasse 35, Basel, Switzerland, 4056www.novartis.com
Teva Pharmaceutical Industries LtdView profile 37,851124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020www.tevapharm.com
Pfizer IncView profile 88,00066 Hudson Boulevard East, New York, NY, United States, 10001-2192www.pfizer.com
Sanofi SAView profile 87,99446, avenue de la Grande Armée, Paris, France, 75017www.sanofi.com
GSK PLC ADRView profile 70,200980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GSwww.gsk.com
Bristol-Myers Squibb CoView profile 34,100Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543www.bms.com
AstraZeneca PLCView profile 89,9001 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AAwww.astrazeneca.com
F. Hoffmann-La Roche Ltd.View profile ---
Mylan N.V.View profile ---

Kuwait Eliquis Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Eliquis Market Outlook will help companies and investors design strategic landscapes.


Atrial Fibrillation (Af) was the largest segment with a revenue share of 45.48% in 2024.

Horizon Databook has segmented the Kuwait eliquis market based on atrial fibrillation (af), deep vein thrombosis (dvt), pulmonary embolism (pe), post-operative vte prophylaxis (at-risk cases) covering the revenue growth of each sub-segment from 2021 to 2033.


  • Kuwait Eliquis Market Indication Outlook (Revenue, USD Million , 2021-2033)
    • Atrial Fibrillation (AF)
    • Deep Vein Thrombosis (DVT)
    • Pulmonary Embolism (PE)
    • Post-Operative VTE Prophylaxis (at-risk cases)
    • Others
  • Kuwait Eliquis Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Reasons to subscribe to Eliquis Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Eliquis Market Outlook databook

  • Our clientele includes a mix of Eliquis Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait Eliquis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Kuwait Eliquis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Kuwait Eliquis Market, 2021-2033 (US$M)

No Access Stack Chart

Kuwait eliquis market statistics, by indication, 2021-2033 (US$M)

No Access Pie Chart

Kuwait eliquis market statistics, by indication, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more